New Study in Diabetic Retinopathy - Interview with Pharmaxis Chief Executive Officer

8th Sep 17

Release Date: 08/09/2017 8:40am

Pharmaceutical research company Pharmaxis (ASX: PXS) today released a video interview with Chief Executive Officer Gary Phillips discussing the announcement that Boehringer Ingelheim is initiating a Phase 2a study in a second disease indication for the drug it acquired from Pharmaxis in 2015.

The five minute video interview can be accessed via the following link:

Categories: News and Media , Video Content